BALTIMORE — Kentucky Derby winner Medina Spirit drew the No. 3 post on Tuesday in a field of 10 horses for Saturday’s Preakness Stakes as the 9-5 morning-line favorite.
The draw came after Preakness officials said they would allow Medina Spirit to enter the 146tth running of the race at Pimlico Race Course. The Bob Baffert-trained horse will be subject to additional testing and monitoring, following the colt’s failed drug test after the Derby.
Medina Spirit and two other horses trained by Bob Baffert will be under extra scrutiny in the days leading up to the second jewel of the Triple Crown. The Maryland Racing Commission and Baffert have agreed to the conditions for Medina Spirit and fellow Preakness runner Concert Tour, as well as Beautiful Gift, who is expected to run in the Black-Eyed Susan Stakes on Friday.
“We reached an agreement with Mr. Baffert and his lawyers that allows for additional testing, additional monitoring — essentially a watch list to ensure the integrity of the sport leading up to the race,” Maryland Jockey Club lawyer Alan Rifkin said. “We’re very pleased to have that and we appreciate Mr. Baffert’s patience and the way in which his lawyers went about it.”
In the draw, Concert Tour drew the outside 10th post and is the second choice in the wagering at 5-2.
Ram drew the No. 1 post at 30-1, Keepmeinmind the No. 2 at 15-1, Crowded Trade the No. 4 post at 10-1, Midnight Bourbon the No. 5 post at 5-1, Rombauer the No. 6 at 12-1, France Go de Ina the No. 7 at 20-1, Unbridled Honor the No. 8 at 15-1 and Risk Taking the No. 9 at 15-1.
Baffert said earlier Tuesday that it was brought to his attention that a veterinarian treated Medina Spirit with an antifungal medication to treat dermatitis that includes the steroid betamethasone. Medina Spirit failed a Kentucky Derby postrace drug test due to the presence of betamethasone.
Maryland Racing’s chief veterinary officer, Dr. Dionne Benson, said at the Preakness draw that test results on the three Baffert horses are expected back Friday. This is an additional layer of blood testing from blood taken last week, Monday and Tuesday on top of the usual postrace tests.
“[The tests] will allow us to ensure that if there is or was any betamethasone or any other medications, whether therapeutic or illegal, in the horse, we will know about them before the race,” Benson said. “Because traditionally most of the testing now will occur after the race, and this allows us to, instead of addressing the issue after the fact, to prevent the issue from becoming a problem.”
Benson said if betamethasone is detected by laboratory testing in any of the horses, officials will ask Baffert to scratch that horse.
